img

Global Antipsychotic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antipsychotic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Antipsychotic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antipsychotic Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Bipolar I Disorder and Schizophrenia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antipsychotic Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antipsychotic Drug key companies include Johnson & Johnson, Pfizer, Eli Lilly, Bristol Myers Squibb, AstraZeneca, Sumitomo Dainippon Pharma, Allergan, Novartis and Cardinal Health, etc. Johnson & Johnson, Pfizer, Eli Lilly are top 3 players and held % share in total in 2022.
Antipsychotic Drug can be divided into First Generation Antipsychotics Drug, Second Generation Antipsychotics Drug and Third generation Antipsychotics Drug,, etc. First Generation Antipsychotics Drug is the mainstream product in the market, accounting for % share globally in 2022.
Antipsychotic Drug is widely used in various fields, such as Bipolar I Disorder, Schizophrenia, Schizoaffective Disorder and Others, etc. Bipolar I Disorder provides greatest supports to the Antipsychotic Drug industry development. In 2022, global % share of Antipsychotic Drug went into Bipolar I Disorder filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antipsychotic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Pfizer
Eli Lilly
Bristol Myers Squibb
AstraZeneca
Sumitomo Dainippon Pharma
Allergan
Novartis
Cardinal Health
Sun Pharmaceutical Industries
GlaxoSmithKline
Sanis Health
Qilu Pharmaceutical
Otsuka Pharmaceutical
Vanda Pharmaceuticals
H.Lundbeck
Organon
Hansoh
Hengrui
Nhwa Group
Yangtze River Pharmaceutical Group
Segment by Type
First Generation Antipsychotics Drug
Second Generation Antipsychotics Drug
Third generation Antipsychotics Drug

Segment by Application


Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antipsychotic Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antipsychotic Drug introduction, etc. Antipsychotic Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Antipsychotic Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Antipsychotic Drug
1.1 Antipsychotic Drug Market Overview
1.1.1 Antipsychotic Drug Product Scope
1.1.2 Antipsychotic Drug Market Status and Outlook
1.2 Global Antipsychotic Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Antipsychotic Drug Market Size by Region (2024-2034)
1.4 Global Antipsychotic Drug Historic Market Size by Region (2024-2024)
1.5 Global Antipsychotic Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Antipsychotic Drug Market Size (2024-2034)
1.6.1 North America Antipsychotic Drug Market Size (2024-2034)
1.6.2 Europe Antipsychotic Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Antipsychotic Drug Market Size (2024-2034)
1.6.4 Latin America Antipsychotic Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Antipsychotic Drug Market Size (2024-2034)
2 Antipsychotic Drug Market by Type
2.1 Introduction
2.1.1 First Generation Antipsychotics Drug
2.1.2 Second Generation Antipsychotics Drug
2.1.3 Third generation Antipsychotics Drug
2.2 Global Antipsychotic Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Antipsychotic Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Antipsychotic Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Antipsychotic Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Antipsychotic Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Antipsychotic Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Antipsychotic Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Antipsychotic Drug Revenue Breakdown by Type (2024-2034)
3 Antipsychotic Drug Market Overview by Application
3.1 Introduction
3.1.1 Bipolar I Disorder
3.1.2 Schizophrenia
3.1.3 Schizoaffective Disorder
3.1.4 Others
3.2 Global Antipsychotic Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Antipsychotic Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Antipsychotic Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Antipsychotic Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Antipsychotic Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Antipsychotic Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Antipsychotic Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Antipsychotic Drug Revenue Breakdown by Application (2024-2034)
4 Antipsychotic Drug Competition Analysis by Players
4.1 Global Antipsychotic Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antipsychotic Drug as of 2022)
4.3 Date of Key Players Enter into Antipsychotic Drug Market
4.4 Global Top Players Antipsychotic Drug Headquarters and Area Served
4.5 Key Players Antipsychotic Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Antipsychotic Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Antipsychotic Drug Products, Services and Solutions
5.1.4 Johnson & Johnson Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Johnson & Johnson Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Antipsychotic Drug Products, Services and Solutions
5.2.4 Pfizer Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Pfizer Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Antipsychotic Drug Products, Services and Solutions
5.3.4 Eli Lilly Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.3.5 Bristol Myers Squibb Recent Developments
5.4 Bristol Myers Squibb
5.4.1 Bristol Myers Squibb Profile
5.4.2 Bristol Myers Squibb Main Business
5.4.3 Bristol Myers Squibb Antipsychotic Drug Products, Services and Solutions
5.4.4 Bristol Myers Squibb Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.4.5 Bristol Myers Squibb Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Profile
5.5.2 AstraZeneca Main Business
5.5.3 AstraZeneca Antipsychotic Drug Products, Services and Solutions
5.5.4 AstraZeneca Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.5.5 AstraZeneca Recent Developments
5.6 Sumitomo Dainippon Pharma
5.6.1 Sumitomo Dainippon Pharma Profile
5.6.2 Sumitomo Dainippon Pharma Main Business
5.6.3 Sumitomo Dainippon Pharma Antipsychotic Drug Products, Services and Solutions
5.6.4 Sumitomo Dainippon Pharma Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Sumitomo Dainippon Pharma Recent Developments
5.7 Allergan
5.7.1 Allergan Profile
5.7.2 Allergan Main Business
5.7.3 Allergan Antipsychotic Drug Products, Services and Solutions
5.7.4 Allergan Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Allergan Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Antipsychotic Drug Products, Services and Solutions
5.8.4 Novartis Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Novartis Recent Developments
5.9 Cardinal Health
5.9.1 Cardinal Health Profile
5.9.2 Cardinal Health Main Business
5.9.3 Cardinal Health Antipsychotic Drug Products, Services and Solutions
5.9.4 Cardinal Health Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Cardinal Health Recent Developments
5.10 Sun Pharmaceutical Industries
5.10.1 Sun Pharmaceutical Industries Profile
5.10.2 Sun Pharmaceutical Industries Main Business
5.10.3 Sun Pharmaceutical Industries Antipsychotic Drug Products, Services and Solutions
5.10.4 Sun Pharmaceutical Industries Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Sun Pharmaceutical Industries Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Profile
5.11.2 GlaxoSmithKline Main Business
5.11.3 GlaxoSmithKline Antipsychotic Drug Products, Services and Solutions
5.11.4 GlaxoSmithKline Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.11.5 GlaxoSmithKline Recent Developments
5.12 Sanis Health
5.12.1 Sanis Health Profile
5.12.2 Sanis Health Main Business
5.12.3 Sanis Health Antipsychotic Drug Products, Services and Solutions
5.12.4 Sanis Health Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Sanis Health Recent Developments
5.13 Qilu Pharmaceutical
5.13.1 Qilu Pharmaceutical Profile
5.13.2 Qilu Pharmaceutical Main Business
5.13.3 Qilu Pharmaceutical Antipsychotic Drug Products, Services and Solutions
5.13.4 Qilu Pharmaceutical Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.13.5 Qilu Pharmaceutical Recent Developments
5.14 Otsuka Pharmaceutical
5.14.1 Otsuka Pharmaceutical Profile
5.14.2 Otsuka Pharmaceutical Main Business
5.14.3 Otsuka Pharmaceutical Antipsychotic Drug Products, Services and Solutions
5.14.4 Otsuka Pharmaceutical Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.14.5 Otsuka Pharmaceutical Recent Developments
5.15 Vanda Pharmaceuticals
5.15.1 Vanda Pharmaceuticals Profile
5.15.2 Vanda Pharmaceuticals Main Business
5.15.3 Vanda Pharmaceuticals Antipsychotic Drug Products, Services and Solutions
5.15.4 Vanda Pharmaceuticals Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.15.5 Vanda Pharmaceuticals Recent Developments
5.16 H.Lundbeck
5.16.1 H.Lundbeck Profile
5.16.2 H.Lundbeck Main Business
5.16.3 H.Lundbeck Antipsychotic Drug Products, Services and Solutions
5.16.4 H.Lundbeck Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.16.5 H.Lundbeck Recent Developments
5.17 Organon
5.17.1 Organon Profile
5.17.2 Organon Main Business
5.17.3 Organon Antipsychotic Drug Products, Services and Solutions
5.17.4 Organon Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.17.5 Organon Recent Developments
5.18 Hansoh
5.18.1 Hansoh Profile
5.18.2 Hansoh Main Business
5.18.3 Hansoh Antipsychotic Drug Products, Services and Solutions
5.18.4 Hansoh Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.18.5 Hansoh Recent Developments
5.19 Hengrui
5.19.1 Hengrui Profile
5.19.2 Hengrui Main Business
5.19.3 Hengrui Antipsychotic Drug Products, Services and Solutions
5.19.4 Hengrui Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.19.5 Hengrui Recent Developments
5.20 Nhwa Group
5.20.1 Nhwa Group Profile
5.20.2 Nhwa Group Main Business
5.20.3 Nhwa Group Antipsychotic Drug Products, Services and Solutions
5.20.4 Nhwa Group Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.20.5 Nhwa Group Recent Developments
5.21 Yangtze River Pharmaceutical Group
5.21.1 Yangtze River Pharmaceutical Group Profile
5.21.2 Yangtze River Pharmaceutical Group Main Business
5.21.3 Yangtze River Pharmaceutical Group Antipsychotic Drug Products, Services and Solutions
5.21.4 Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue (US$ Million) & (2024-2024)
5.21.5 Yangtze River Pharmaceutical Group Recent Developments
6 North America
6.1 North America Antipsychotic Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Antipsychotic Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antipsychotic Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antipsychotic Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antipsychotic Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antipsychotic Drug Market Dynamics
11.1 Antipsychotic Drug Industry Trends
11.2 Antipsychotic Drug Market Drivers
11.3 Antipsychotic Drug Market Challenges
11.4 Antipsychotic Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antipsychotic Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Antipsychotic Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Antipsychotic Drug Market Size Share by Region (2024-2024)
Table 4. Global Antipsychotic Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Antipsychotic Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Antipsychotic Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Antipsychotic Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Antipsychotic Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Antipsychotic Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Antipsychotic Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Antipsychotic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Antipsychotic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Antipsychotic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Antipsychotic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Antipsychotic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Antipsychotic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Antipsychotic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Antipsychotic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Antipsychotic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Antipsychotic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Antipsychotic Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Antipsychotic Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Antipsychotic Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Antipsychotic Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Antipsychotic Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Antipsychotic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Antipsychotic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Antipsychotic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Antipsychotic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Antipsychotic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Antipsychotic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Antipsychotic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Antipsychotic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Antipsychotic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Antipsychotic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Antipsychotic Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Antipsychotic Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antipsychotic Drug as of 2022)
Table 39. Date of Key Players Enter into Antipsychotic Drug Market
Table 40. Global Antipsychotic Drug Key Players Headquarters and Area Served
Table 41. Antipsychotic Drug Product Solution and Service
Table 42. Global Antipsychotic Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Johnson & Johnson Basic Information List
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Antipsychotic Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antipsychotic Drug Business of Johnson & Johnson (2024-2024)
Table 48. Johnson & Johnson Recent Developments
Table 49. Pfizer Basic Information List
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Antipsychotic Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antipsychotic Drug Business of Pfizer (2024-2024)
Table 53. Pfizer Recent Developments
Table 54. Eli Lilly Basic Information List
Table 55. Eli Lilly Description and Business Overview
Table 56. Eli Lilly Antipsychotic Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antipsychotic Drug Business of Eli Lilly (2024-2024)
Table 58. Eli Lilly Recent Developments
Table 59. Bristol Myers Squibb Basic Information List
Table 60. Bristol Myers Squibb Description and Business Overview
Table 61. Bristol Myers Squibb Antipsychotic Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Antipsychotic Drug Business of Bristol Myers Squibb (2024-2024)
Table 63. Bristol Myers Squibb Recent Developments
Table 64. AstraZeneca Basic Information List
Table 65. AstraZeneca Description and Business Overview
Table 66. AstraZeneca Antipsychotic Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Antipsychotic Drug Business of AstraZeneca (2024-2024)
Table 68. AstraZeneca Recent Developments
Table 69. Sumitomo Dainippon Pharma Basic Information List
Table 70. Sumitomo Dainippon Pharma Description and Business Overview
Table 71. Sumitomo Dainippon Pharma Antipsychotic Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Antipsychotic Drug Business of Sumitomo Dainippon Pharma (2024-2024)
Table 73. Sumitomo Dainippon Pharma Recent Developments
Table 74. Allergan Basic Information List
Table 75. Allergan Description and Business Overview
Table 76. Allergan Antipsychotic Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Antipsychotic Drug Business of Allergan (2024-2024)
Table 78. Allergan Recent Developments
Table 79. Novartis Basic Information List
Table 80. Novartis Description and Business Overview
Table 81. Novartis Antipsychotic Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Antipsychotic Drug Business of Novartis (2024-2024)
Table 83. Novartis Recent Developments
Table 84. Cardinal Health Basic Information List
Table 85. Cardinal Health Description and Business Overview
Table 86. Cardinal Health Antipsychotic Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Antipsychotic Drug Business of Cardinal Health (2024-2024)
Table 88. Cardinal Health Recent Developments
Table 89. Sun Pharmaceutical Industries Basic Information List
Table 90. Sun Pharmaceutical Industries Description and Business Overview
Table 91. Sun Pharmaceutical Industries Antipsychotic Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Antipsychotic Drug Business of Sun Pharmaceutical Industries (2024-2024)
Table 93. Sun Pharmaceutical Industries Recent Developments
Table 94. GlaxoSmithKline Basic Information List
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Antipsychotic Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Antipsychotic Drug Business of GlaxoSmithKline (2024-2024)
Table 98. GlaxoSmithKline Recent Developments
Table 99. Sanis Health Basic Information List
Table 100. Sanis Health Description and Business Overview
Table 101. Sanis Health Antipsychotic Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Antipsychotic Drug Business of Sanis Health (2024-2024)
Table 103. Sanis Health Recent Developments
Table 104. Qilu Pharmaceutical Basic Information List
Table 105. Qilu Pharmaceutical Description and Business Overview
Table 106. Qilu Pharmaceutical Antipsychotic Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Antipsychotic Drug Business of Qilu Pharmaceutical (2024-2024)
Table 108. Qilu Pharmaceutical Recent Developments
Table 109. Otsuka Pharmaceutical Basic Information List
Table 110. Otsuka Pharmaceutical Description and Business Overview
Table 111. Otsuka Pharmaceutical Antipsychotic Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Antipsychotic Drug Business of Otsuka Pharmaceutical (2024-2024)
Table 113. Otsuka Pharmaceutical Recent Developments
Table 114. Vanda Pharmaceuticals Basic Information List
Table 115. Vanda Pharmaceuticals Description and Business Overview
Table 116. Vanda Pharmaceuticals Antipsychotic Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Antipsychotic Drug Business of Vanda Pharmaceuticals (2024-2024)
Table 118. Vanda Pharmaceuticals Recent Developments
Table 119. H.Lundbeck Basic Information List
Table 120. H.Lundbeck Description and Business Overview
Table 121. H.Lundbeck Antipsychotic Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Antipsychotic Drug Business of H.Lundbeck (2024-2024)
Table 123. H.Lundbeck Recent Developments
Table 124. Organon Basic Information List
Table 125. Organon Description and Business Overview
Table 126. Organon Antipsychotic Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Antipsychotic Drug Business of Organon (2024-2024)
Table 128. Organon Recent Developments
Table 129. Hansoh Basic Information List
Table 130. Hansoh Description and Business Overview
Table 131. Hansoh Antipsychotic Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Antipsychotic Drug Business of Hansoh (2024-2024)
Table 133. Hansoh Recent Developments
Table 134. Hengrui Basic Information List
Table 135. Hengrui Description and Business Overview
Table 136. Hengrui Antipsychotic Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Antipsychotic Drug Business of Hengrui (2024-2024)
Table 138. Hengrui Recent Developments
Table 139. Nhwa Group Basic Information List
Table 140. Nhwa Group Description and Business Overview
Table 141. Nhwa Group Antipsychotic Drug Products, Services and Solutions
Table 142. Revenue (US$ Million) in Antipsychotic Drug Business of Nhwa Group (2024-2024)
Table 143. Nhwa Group Recent Developments
Table 144. Yangtze River Pharmaceutical Group Basic Information List
Table 145. Yangtze River Pharmaceutical Group Description and Business Overview
Table 146. Yangtze River Pharmaceutical Group Antipsychotic Drug Products, Services and Solutions
Table 147. Revenue (US$ Million) in Antipsychotic Drug Business of Yangtze River Pharmaceutical Group (2024-2024)
Table 148. Yangtze River Pharmaceutical Group Recent Developments
Table 149. North America Antipsychotic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 150. North America Antipsychotic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 151. Europe Antipsychotic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 152. Europe Antipsychotic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 153. Asia-Pacific Antipsychotic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 154. Asia-Pacific Antipsychotic Drug Market Size by Region (2024-2024) & (US$ Million)
Table 155. Asia-Pacific Antipsychotic Drug Market Size by Region (2024-2034) & (US$ Million)
Table 156. Asia-Pacific Antipsychotic Drug Market Share by Region (2024-2024)
Table 157. Asia-Pacific Antipsychotic Drug Market Share by Region (2024-2034)
Table 158. Latin America Antipsychotic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 159. Latin America Antipsychotic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 160. Latin America Antipsychotic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 161. Middle East & Africa Antipsychotic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 162. Middle East & Africa Antipsychotic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 163. Middle East & Africa Antipsychotic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 164. Antipsychotic Drug Market Trends
Table 165. Antipsychotic Drug Market Drivers
Table 166. Antipsychotic Drug Market Challenges
Table 167. Antipsychotic Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antipsychotic Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Antipsychotic Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Antipsychotic Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Antipsychotic Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Antipsychotic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Antipsychotic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Antipsychotic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Antipsychotic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Antipsychotic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of First Generation Antipsychotics Drug
Figure 11. Global First Generation Antipsychotics Drug Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Second Generation Antipsychotics Drug
Figure 13. Global Second Generation Antipsychotics Drug Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Third generation Antipsychotics Drug
Figure 15. Global Third generation Antipsychotics Drug Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Antipsychotic Drug Market Size Share by Type: 2022 & 2034
Figure 17. North America Antipsychotic Drug Revenue Market Share by Type (2024-2034)
Figure 18. Europe Antipsychotic Drug Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Antipsychotic Drug Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Antipsychotic Drug Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Antipsychotic Drug Revenue Market Share by Type (2024-2034)
Figure 22. Bipolar I Disorder Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Schizophrenia Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Schizoaffective Disorder Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Global Antipsychotic Drug Market Size Share by Application: 2022 & 2034
Figure 27. North America Antipsychotic Drug Revenue Market Share by Application (2024-2034)
Figure 28. Europe Antipsychotic Drug Revenue Market Share by Application (2024-2034)
Figure 29. Asia-Pacific Antipsychotic Drug Revenue Market Share by Application (2024-2034)
Figure 30. Latin America Antipsychotic Drug Revenue Market Share by Application (2024-2034)
Figure 31. Middle East and Africa Antipsychotic Drug Revenue Market Share by Application (2024-2034)
Figure 32. Antipsychotic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 33. Global Top 5 and Top 10 Players Antipsychotic Drug Market Share in 2022
Figure 34. North America Antipsychotic Drug Market Share by Country (2024-2034)
Figure 35. United States Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 36. Canada Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 37. Germany Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 38. France Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 39. U.K. Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 40. Italy Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Russia Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Nordic Countries Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 43. Asia-Pacific Antipsychotic Drug Market Share by Region (2024-2034)
Figure 44. China Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 45. Japan Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 46. South Korea Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 47. Southeast Asia Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 48. India Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Australia Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 50. Latin America Antipsychotic Drug Market Share by Country (2024-2034)
Figure 51. Mexico Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Brazil Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 53. Middle East & Africa Antipsychotic Drug Market Share by Country (2024-2034)
Figure 54. Turkey Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 56. UAE Antipsychotic Drug Market Size (2024-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report